000 01013 a2200301 4500
005 20250517024024.0
264 0 _c20150601
008 201506s 0 0 eng d
022 _a1474-1784
024 7 _a10.1038/nrd4571
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSyed, Basharut A
245 0 0 _aThe breast cancer market.
_h[electronic resource]
260 _bNature reviews. Drug discovery
_cApr 2015
300 _a233-4 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xeconomics
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCancer Vaccines
_xeconomics
650 0 4 _aDrug Industry
_xeducation
650 0 4 _aFemale
650 0 4 _aHealth Care Sector
_xeconomics
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xeconomics
650 0 4 _aReceptor, ErbB-2
_xgenetics
773 0 _tNature reviews. Drug discovery
_gvol. 14
_gno. 4
_gp. 233-4
856 4 0 _uhttps://doi.org/10.1038/nrd4571
_zAvailable from publisher's website
999 _c24761824
_d24761824